AstraZeneca Options Trading: A Deep Dive Into Market Sentiment
AstraZeneca Options Trading: A Deep Dive Into Market Sentiment
In terms of liquidity and interest, the mean open interest for AstraZeneca options trades today is 2727.71 with a total volume of 14,580.00.Financial giants have made a conspicuous bearish move on AstraZeneca. Our analysis of options history for AstraZeneca (NASDAQ:AZN) revealed 9 unusual trades.
金融巨头对阿斯利康采取了明显的看跌动作。我们对阿斯利康（纳斯达克：AZN）期权历史进行了分析，发现了9笔异常交易。
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $353,099, and 5 were calls, valued at $822,380.
深入研究细节，我们发现33％的交易者看涨，而66％的交易者看淡。在我们发现的所有交易中，有4笔看跌交易，价值353,099美元，还有5笔看涨交易，价值822,380美元。
Projected Price Targets
预计价格目标
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $79.0 and $87.5 for AstraZeneca, spanning the last three months.
在评估交易量和未平仓合约之后，明显可见主要市场动态集中在阿斯利康价格在79.0至87.5美元之间的区间，涵盖了过去三个月。
Volume & Open Interest Trends
成交量和未平仓量趋势
In terms of liquidity and interest, the mean open interest for AstraZeneca options trades today is 2727.71 with a total volume of 14,580.00.
在流动性和利益方面，阿斯利康期权交易的平均未平仓合约为2727.71，总成交量为14,580.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for AstraZeneca's big money trades within a strike price range of $79.0 to $87.5 over the last 30 days.
在下面的图表中，我们可以追踪阿斯利康的看涨和看跌期权的成交量和未平仓合约的发展，范围为79.0至87.5美元，时间跨度为30天。
AstraZeneca Option Activity Analysis: Last 30 Days
阿斯利康期权活动分析：过去30天
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZN | CALL | TRADE | BULLISH | 09/20/24 | $0.86 | $0.8 | $0.85 | $85.00 | $671.5K | 3.6K | 7.9K |
| AZN | PUT | TRADE | BULLISH | 10/11/24 | $0.81 | $0.57 | $0.61 | $79.00 | $250.1K | 0 | 4.1K |
| AZN | CALL | SWEEP | BEARISH | 01/17/25 | $4.3 | $4.25 | $4.25 | $85.00 | $42.5K | 1.3K | 132 |
| AZN | CALL | SWEEP | BULLISH | 01/17/25 | $4.25 | $4.2 | $4.25 | $85.00 | $42.4K | 1.3K | 232 |
| AZN | PUT | SWEEP | BEARISH | 09/20/24 | $2.16 | $2.13 | $2.16 | $85.00 | $41.6K | 5.3K | 634 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZN | 看涨 | 交易 | 看好 | 09/20/24 | 每股0.86美元 | $0.8 | $0.85 | $85.00 | $671.5千美元 | 3.6千 | 7.9K |
| AZN | 看跌 | 交易 | 看好 | 10/11/24 | $0.81 | $0.57 | $0.61 | 79.00美元 | $250.1K | 0 | 4.1K |
| AZN | 看涨 | SWEEP | 看淡 | 01/17/25 | $4.3 | $4.25 | $4.25 | $85.00 | $42.5K | 1.3K | 132 |
| AZN | 看涨 | SWEEP | 看好 | 01/17/25 | $4.25 | $4.2 | $4.25 | $85.00 | $42.4K | 1.3K | 232 |
| AZN | 看跌 | SWEEP | 看淡 | 09/20/24 | $2.16 | $2.13 | $2.16 | $85.00 | $41.6千 | 5.3K | 634 |
About AstraZeneca
关于阿斯利康
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
1999年，瑞典的Astra与英国的Zeneca集团合并，形成了阿斯利康。该公司销售品牌药物，涵盖多个重要的治疗领域，包括消化系统、糖尿病、心血管、呼吸系统、癌症、免疫和罕见疾病。大部分销售额来自国际市场，美国销售额占其销售总额的近三分之一。
Following our analysis of the options activities associated with AstraZeneca, we pivot to a closer look at the company's own performance.
在对阿斯利康期权活动进行分析后，我们转向更近距离地观察公司自身的表现。
Where Is AstraZeneca Standing Right Now?
阿斯利康目前处于什么地步？
- With a volume of 4,170,981, the price of AZN is down -3.44% at $82.8.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 63 days.
- 成交量为4,170,981，AZN的价格下跌了-3.44%，报$82.8。
- RSI指标暗示该标的股票目前处于超买和超卖的中立区间。
- 下一次财报预计在63天发布。
What Analysts Are Saying About AstraZeneca
关于阿斯利康的分析师看法
In the last month, 1 experts released ratings on this stock with an average target price of $95.0.
在过去一个月中，有1位专家对这只股票进行了评级，平均目标价为95.0美元。
- An analyst from TD Cowen persists with their Buy rating on AstraZeneca, maintaining a target price of $95.
- TD Cowen的分析师坚持对阿斯利康的买入评级，并维持95美元的目标价。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AstraZeneca with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略性的交易调整、利用各种因子，并保持对市场动态的敏锐，来减轻这些风险。使用Benzinga Pro实时警报，随时了解阿斯利康的最新期权交易。
